Baker Bros. Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Baker Bros. Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-96,062	Closed	-$8.85M	–	126
2017 Q3	$8.85M	Sell	96,062 -42,250	-31%	-$3.28M	0.07%	54
2017 Q2	$11.1M	Buy	138,312 +577	+0.4%	+$32K	0.1%	46
2017 Q1	$5.8M	Hold	137,735	–	–	0.05%	62
2016 Q4	$4.42M	Hold	137,735	–	–	0.04%	69
2016 Q3	$3.61M	Hold	137,735	–	–	0.03%	75
2016 Q2	$3.19M	Hold	137,735	–	–	0.03%	80
2016 Q1	$3.77M	Hold	137,735	–	–	0.04%	79
2015 Q4	$3.92M	Buy	137,735 +37,735	+38%	+$1.01M	0.03%	86
2015 Q3	$1.75M	Hold	100,000	–	–	0.02%	108
2015 Q2	$1.8M	Hold	100,000	–	–	0.02%	107
2015 Q1	$1.25M	Hold	100,000	–	–	0.01%	117
2014 Q4	$1.18M	Hold	100,000	–	–	0.01%	109
2014 Q3	$1.31M	Buy	+100,000	New	+$1.3M	0.02%	97

Other funds holding LOXO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Baker Bros. Advisors's LOXO Position: Q4 2017 in Review

Baker Bros. Advisors sold out of Loxo Oncology, Inc (LOXO) in Q4 2017, closing a stake of 96,062 shares — an estimated $8.85M sold.

Baker Bros. Advisors first reported a position in LOXO in Q3 2014 and held it in 13 quarters. The position peaked at $11.1M in Q2 2017. 141 funds tracked by Wall St. Rank hold LOXO as of Q4 2017.

Baker Bros. Advisors reported no remaining Loxo Oncology, Inc position as of Q4 2017 after selling out during the quarter.
Baker Bros. Advisors sold 96,062 Loxo Oncology, Inc shares in Q4 2017, an estimated $8.85M.
Baker Bros. Advisors first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 13 quarters.
Baker Bros. Advisors's Loxo Oncology, Inc position peaked at $11.1M in Q2 2017.
141 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2017.

Based on Baker Bros. Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.